Jeil Pharmaceutical Co.,Ltd (KRX:271980)

South Korea · Delayed Price · Currency is KRW

10,100

-60 (-0.59%)

Sep 11, 2026, 3:30 PM KST

KRX:271980 Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	543,495	567,244	704,542	726,394	722,230	700,693
Revenue Growth	-17.85%	-19.49%	-3.01%	0.58%	3.07%	1.35%
Gross Profit	220,028	212,904	177,495	184,256	156,798	155,571
Operating Income	4,079	20,995	-18,550	8,888	-13,332	-10,380
Net Income	9,317	23,384	-29,968	5,005	-13,091	-12,473
Earnings Per Share	637.36	1604.77	-2057.00	343.46	-898.19	-853.81
EPS Growth	79.85%	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	67,407	58,832	57,455	35,658	31,589	28,003
Total Debt	112,277	93,416	75,695	71,170	54,350	47,800
Net Cash (Debt)	-44,870	-34,585	-18,240	-35,513	-22,761	-19,797
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-3069.44	-2373.44	-1252.00	-2437.13	-1561.68	-1355.11

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-3,075	-5,690	3,213	-4,981	-15,147	19,100
Capital Expenditures	-12,741	-8,032	-4,278	-6,097	-11,085	-5,344
Free Cash Flow	-15,816	-13,722	-1,065	-11,077	-26,232	13,756
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	40.48%	37.53%	25.19%	25.37%	21.71%	22.20%
Operating Margin	0.75%	3.70%	-2.63%	1.22%	-1.85%	-1.48%
Pretax Margin	3.44%	6.16%	-3.83%	0.26%	-1.83%	-1.97%
Profit Margin	1.71%	4.12%	-4.25%	0.69%	-1.81%	-1.78%
FCF Margin	-2.91%	-2.42%	-0.15%	-1.52%	-3.63%	1.96%

Dividends

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Dividend Per Share	50.000	50.000
Dividend Per Share Growth	0%	-
Dividend Yield	0.29%	0.24%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	15.85	9.44	-	49.79	-	-
P/FCF Ratio	-	-	-	-	-	35.94
PS Ratio	0.27	0.39	0.24	0.34	0.42	0.71